Regulatory28 May 2026, 10:29 pm
Clinitech Reports No Deviation in IPO Fund Utilization as of Mar 2026
AI Summary
Clinitech Laboratory Limited has filed a statement confirming no deviation or variation in the utilization of funds raised through its Public Issue (IPO) as of March 31, 2026. The company raised ₹578.30 Lakhs on July 30, 2024. Funds were primarily allocated for the expansion of diagnostic centres (₹498.67 Lakhs), general corporate purposes (₹41.33 Lakhs), and issue-related expenses (₹38.30 Lakhs). As of the reporting quarter, ₹528.30 Lakhs has been utilized, with the company asserting full adherence to the original objects of the issue.
Key Highlights
- Clinitech confirms no deviation in IPO fund usage as of March 31, 2026.
- Company raised ₹578.30 Lakhs through IPO on July 30, 2024.
- Funds allocated for diagnostic centre expansion and corporate purposes.
- Total ₹528.30 Lakhs utilized from the IPO proceeds to date.
Price Impact
More from CTLLAB